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This response clarifies certain misconceptions published
in the commentary by Bevelacqua et al. (2019).
We are pleased that our article entitled “New concerns for
neurocognitive function during deep space exposures to
chronic, low dose rate, neutron radiation” (Acharya et al.,
2019) has stimulated interesting discussions and different
perspectives on what may or may not be relevant to esti-
mating the risks of CNS dysfunction following exposure to
the space radiation environment. Here we provide our re-
sponse to the commentary from Bevelacqua et al. (2019).
Bevelacqua et al. (2019) stated that there were a few
major shortcomings with our approach, and wewould like to
clarify our stance regarding those statements. The first and
perhaps most disconcerting statement was their assertion
that we have ignored “. . .that in a realistic space environ-
ment, cells will be exposed tomultiple low LET (linear energy
transfer) protons before being traversed by intermediate and
high-LET HZE (high charge and energy) particles.” The au-
thors of Acharya et al. (2019) have conducted research at
heavy ion particle accelerators around the world for more
than a decade, and the implication that we might be un-
aware of the complexities of the radiation fields in space is
misguided (Parihar et al., 2015, 2016, 2018; Lee et al., 2017).
During long-term missions into deep space, astronauts will
be exposed to a complex radiation field that includes high LET
components from high energy, heavy ions (HZE particles) at
lowdose ratesof0.5mGy/d for longdurations. About 20%of
the dose is delivered with LET 10 keV/m.
Particle accelerators are capable of simulating compo-
nents of the galactic cosmic radiation (GCR) spectrum. The
main impediment to performing accelerator-based experi-
ments, which are designed to simulate exposures to high
LET radiations during extended missions in space, is that it
is not reasonable to irradiate large numbers of rodents con-
tinuously over many months at meaningful and relevant
doses and dose rates. Fast neutrons from nuclear fission
create charged particle nuclei in tissues that have an LET
ranging from 10 to 200 keV/m. We were careful not to
imply that the radiation environment in the 252Cf facility is an
exact replica of conditions within a spacecraft or habitat in
deep space. However, the charged particles generated by
neutrons are produced uniformly in small animals with a
dose-averaged LET that is similar to many of the HZE com-
ponents of the GCR and about a factor of two higher than
space radiation fields resulting from penetrating particles
and nuclear fragmentation downstream of shielding.
We disagree with the statement that precision mea-
surements of dose rates and radiation quality for the
mixed fields within this facility are “. . .significantly easier
than determining the dose from a spectrum of protons
and HZE particles of much greater energy.” Complex
dosimetry was required for a large facility capable of
exposing 900 mice and 60 rats simultaneously. The radi-
ation field at the exposure location consists of direct
neutrons from the source as well as albedo neutrons from
the walls and floor. There is also a component of direct
photons emitted from the source and scattered photons
from the surrounding shielding. Tissue equivalent propor-
tional counters (TEPCs) were used to measure neutrons.
A miniature GM (Geiger-Müller) counter and CaF2 ther-
moluminescent dosimeters were used to measure pho-
tons. Data from the TEPCs provide direct estimates of the
dose rate from neutrons around the room as well as
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patterns of energy deposition in volumes of tissue similar
to the size of a mammalian cell (i.e., lineal energy). These
data encompass all the direct and complex environmental
modifications to the radiation exposures. Eighty percent
of the total dose is from nuclear recoil particles produced
by neutron interactions in tissue and 20% is from incident
photons. Further details regarding the radiation dosimetry
of this facility have been published (Borak et al., 2019).
The authors correctly point out that the animals in the
252Cf facility are not subjected to “multiple low LET pro-
tons before being traversed by intermediate and high LET
particles.” They imply that this sequential process of ex-
posure can lead to the induction of adaptive responses in
space. However, it must be noted that in our 252Cf facility
animals are exposed continuously to low LET photons
with intermittent production high LET nuclear recoils.
The assertion that this study should have taken into
account the possibility of adaptive responses seems mis-
guided. Adaptive responses have never been convinc-
ingly demonstrated in vivo and are considered by many
radiobiologists to be artifacts of in vitro cell culture (Sowa
et al., 2010, 2011). To that end, none of the references
provided in the commentary documented conclusive ev-
idence regarding the adaptive response in vivo, much less
in the CNS. Further, the idea that functional CNS end
points such as cognition, behavior, and electrophysiology
would resemble what has been found using in vitro cul-
tures of various cancer cell lines is incongruous. Precisely
how in vitro studies using transformed cancer cells can
shed any light on the functionality of an intact brain is
unclear. No agency responsible for radiation protection
has incorporated adaptive response into risk assessment
models because this effect is not adequately supported in
animals or humans.
We are confused with the authors criticism of this work
based on the premise that “The absorbed dose does not
correspond to a biological detriment.” The suggestion of
Bevelacqua et al. (2019) to introduce International Commis-
sion on Radiologic Protection stochastic quality factors or
radiationweighting factors ismeaningless for neurocognitive
function. These dose-modifying factors are based on carci-
nogenesis in humans with most information derived from
acute exposures. The objectives of investigations at the
252Cf facility are to establish dose, dose rate, and radiation
quality effects on biological end points that are beyond the
reach of other available experimental protocols. It could be
argued that these results will provide valuable information for
creating the next generation of dose-modifying factors for
radiation risk analysis.
One of the primary driving forces for establishing the
neutron facility at Colorado State University was to investi-
gate dose rate effects, since there is a large and reproduc-
ible body of literature demonstrating that lowering the dose
rate (in cGy/h) provides for the temporal overlap of DNA
repair during dose delivery. The end result is that nearly all of
the adverse effects of exposure to ionizing radiation are
ameliorated at low dose rates simply due to effective DNA
repair. It stands to reason then that at space-relevant dose
rates similar reductions in adverse effects would be ob-
served, which was not the case in the study by Acharya et al.
(2019). It is also important to keep in mind that a critical
difference between the study by Acharya et al. (2019) and
the references cited by Bevelacqua et al. (2019) is that we
did not investigate putative carcinogenic end points in cul-
tured cells. Dose rate effects can be expected to play a
relativelyminor role in a largely postmitotic organ such as the
brain, especially when considering the multifaceted func-
tions that characterize the CNS. At the low doses and dose
rates used in Acharya et al. (2019) radiation effects are not
likely the result of cell killing, but rather an accumulation of
damage to networks of cells that adversely impact neu-
rotransmission.
Regardless of the mechanism, findings from the study
by Acharya et al. (2019) demonstrated significant impair-
ments in the brain under the stated irradiation conditions,
with no evidence for attenuation by adaptive and/or DNA
repair processes over the protracted exposure time. De-
spite our disagreements with the commentary proffered,
we hope these discussions can help the National Aero-
nautics and Space Administration and other agencies
properly evaluate the CNS risks associated with exposure
to the deep space radiation environment (Limoli, 2017).
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